<?xml version="1.0" ?>
<document id="27480663">
  <sentence id="27480663.s0" text="This phenotypic variability should be taken into account when treating patients with positive regulation of protein phosphorylation-associated neurodegenerative disease.">
    <entity charOffset="85-131" id="27480663.s0.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="143-168" id="27480663.s0.e1" ontology_id="HP_0002180" text="neurodegenerative disease" type="HP"/>
    <pair e1="27480663.s0.e0" e2="27480663.s0.e1" id="27480663.s0.p0" relation="true"/>
  </sentence>
  <sentence id="27480663.s1" text="Recessive mutations in positive regulation of protein phosphorylation cause lethal neonatal rigidity and multifocal seizure syndrome, a phenotype characterized by neonatal microcephaly, hypertonia, and refractory epilepsy with premature death by age 2 years.">
    <entity charOffset="23-69" id="27480663.s1.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="213-221" id="27480663.s1.e1" ontology_id="HP_0001250" text="epilepsy" type="HP"/>
    <pair e1="27480663.s1.e0" e2="27480663.s1.e1" id="27480663.s1.p0" relation="true"/>
  </sentence>
  <sentence id="27480663.s2" text="Here, we report two affected siblings with compound heterozygous truncating mutations in positive regulation of protein phosphorylation and intra-familial phenotypic heterogeneity, with a less severe disease course in the female sibling.">
    <entity charOffset="89-135" id="27480663.s2.e0" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <entity charOffset="166-179" id="27480663.s2.e1" ontology_id="HP_0001425" text="heterogeneity" type="HP"/>
    <pair e1="27480663.s2.e0" e2="27480663.s2.e1" id="27480663.s2.p0" relation="true"/>
  </sentence>
</document>
